ARQT (Arcutis) Net Profit

ARQT (arcutis.com) - company brandmark

Arcutis Biotherapeutics (ARQT) leverages its patent portfolio in dermatology to develop high-margin creams. The GURU.Markets terminal displays a chart of the company's bottom line, where 0.03 defines the current value of the metric. Successful sales of psoriasis treatments have halted the depletion of reserves, strengthening the balance sheet. Revenues are based on the sale of innovative non-steroidal products through pharmacy chains.

ARQT (Arcutis Biotherapeutics) Company Net Income history from 07/04/2022 to 11/01/2026

Financial and market metric breakdowns for Arcutis Biotherapeutics, Inc. (ARQT)

- price and consensus price forecast:
Stock Quotes Arcutis Corp|ARQT - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Arcutis Corp|ARQT - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Arcutis Biotherapeutics|ARQT - Company Book Value|Market Capitalization to Book Value arcutis.com|ARQT - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Arcutis Biotherapeutics|ARQT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Arcutis|ARQT - Company Debts|Debt to Book Value Ratio Arcutis Corp|ARQT - Company Long-Term Debts|Company Short-Term Debts Arcutis Biotherapeutics|Intermediate Coverage Ratio arcutis.com
- net income and valuation multiples indicators:
ARQT - Net Profit
Basic company analysis:Arcutis Corp
Manufactured product of Arcutis Biotherapeutics Inc

Retaining the core R&D team and expanding the commercial departments of Arcutis Biotherapeutics (ARQT) establish the foundation for future cash flows. This financial performance metric measures aggregate revenue in real-time, allowing investors to use the chart's price action to assess the risk of overpaying for the asset and find a balance between capital preservation and potential returns in the competitive US market.

Direct competitors

Net Income Krystal Biotech Corp.|APGE (Apogee Therapeutics) - Net Profit|Net Profit vcel.com|Net Income ORKA (Oruka Therapeutics)|SMTI (sanaramedtech.com) - Final Profit|Company Net Income DBV Technologies DBVT|Net Financial Result Solesence Beauty (SLSN)|DERM - Company Net Income|FBRX - Net Profit|EMPG: Net Profit|SLGL - Net Financial Result|Company Net Income AXIL Brands Inc|Company Profit MDCX (Medicus Pharma Corp)|Net Profit VRCA|Net Profit hoththerapeutics.com (HOTH)|Company Net Income Biofrontera BFRI|Final Profit VYNE|Sonoma Pharma - Net Profit|Quoin Pharmaceuticals (QNRX) - Net Income|AZTR (Azitra, Inc.) - Net Income|dermatarx.com (DRMA) - Net Profit|Net Income ELAB|RVNC (Revance Therapeutics Inc.) - Profit After Payment of Taxes